Participants:18–64 years · 65+ years
Substances:4-[3-(Cyanomethyl)-3-(3',5'-Dimethyl-1H,1'H-[4,4'-Bipyrazol]-1-Yl)Azetidin-1-Yl]-2,5-Difluoro-N-[(2S)-1,1,1-Trifluoropropan-2-Yl]Benzamide

Contact Research Centre

Psoriasis

Not recruiting

Registered drug

Study on the Effectiveness and Safety of ESK-001 and Apremilast for Adults with Moderate to Severe Plaque Psoriasis

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Apremilast

Contact Research Centre

Dermatitis atopic

Not recruiting

Investigational

Study on the Safety and Effectiveness of APG777 for Patients with Moderate-to-Severe Atopic Dermatitis

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Apg777

Contact Research Centre

Dermatitis atopic

Not recruiting

Investigational

Study on the Effects of PF-07275315 and PF-07264660 for Adults with Moderate to Severe Atopic Dermatitis

Investigational

Germany

Participants:18–64 years · 65+ years

Contact Research Centre

Neurodermatitis

Not recruiting

Investigational

Study on the Effects of Barzolvolimab for Patients with Prurigo Nodularis

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Barzolvolimab

Contact Research Centre

Dermatitis atopic

Not recruiting

InvestigationalNo placebo

Study on the Long-Term Safety and Efficacy of Nemolizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

InvestigationalNo placebo

Germany

Participants:0–17 years · 18–64 years · 65+ years
Substances:Nemolizumab

Contact Research Centre

Hidradenitis

Not recruiting

Investigational

Study on the Effects of Sonelokimab for Adults with Moderate to Severe Hidradenitis Suppurativa

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Sonelokimab

Contact Research Centre

Neurodermatitis

Not recruiting

InvestigationalNo placebo

Study on the Long-Term Safety and Effectiveness of Nemolizumab for Patients with Prurigo Nodularis

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Nemolizumab

Contact Research Centre

Find therapies in clinical trials near you – page 5

111 trials match your criteria

Psoriasis

Study on Long-term Safety and Effectiveness of ESK-001 for Patients with Moderate to Severe Plaque Psoriasis

Dermatitis atopic

Study on the Effectiveness and Safety of JNJ-95475939 and Dupilumab for Treating Moderate to Severe Atopic Dermatitis in Adults

Psoriatic arthropathy

Study of sonelokimab injection in adults with active psoriatic arthritis who have not received biological DMARDs treatment before

Psoriasis

Study on Long-term Safety and Effectiveness of Zasocitinib for Patients with Moderate-to-Severe Plaque Psoriasis

Neurodermatitis

Study on the Effects of Povorcitinib for Patients with Prurigo Nodularis

Psoriasis

Study on the Effectiveness and Safety of ESK-001 and Apremilast for Adults with Moderate to Severe Plaque Psoriasis

Dermatitis atopic

Study on the Safety and Effectiveness of APG777 for Patients with Moderate-to-Severe Atopic Dermatitis

Dermatitis atopic

Study on the Effects of PF-07275315 and PF-07264660 for Adults with Moderate to Severe Atopic Dermatitis

Neurodermatitis

Study on the Effects of Barzolvolimab for Patients with Prurigo Nodularis

Dermatitis atopic

Study on the Long-Term Safety and Efficacy of Nemolizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

Hidradenitis

Study on the Effects of Sonelokimab for Adults with Moderate to Severe Hidradenitis Suppurativa

Neurodermatitis

Study on the Long-Term Safety and Effectiveness of Nemolizumab for Patients with Prurigo Nodularis

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.